| Vol. 6.27 – 29 July, 2022 |
| |
|
|
| Researchers showed that triclosan, a high-volume antimicrobial additive that was detected in human breast milk, could be efficiently transferred by lactation to newborn mice, causing significant fatty liver during the suckling period. [Nature Communications] |
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors suggested that glutamine synthase 2 (GLS2) was a bona fide tumor suppressor and that its ability to favor ferroptosis by regulating glutaminolysis contributed to its tumor suppressive function. [Cancer Research] |
|
|
|
| Scientists reported a mechanism of cell division control in the postnatal liver, in which Wnt/β-catenin signaling maintained active hepatocyte cell division through Tbx3, a Wnt target gene. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Researchers reported a mechanism of cell division control in the postnatal liver, in which Wnt/β-catenin signaling maintained active hepatocyte cell division through Tbx3, a Wnt target gene. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Investigators reported hemochromatosis (HFE) as an oncogene in HCC and its undescribed function on promoting abscission in cytokinesis during mitotic cell division, independent of its iron-regulating ability. [Oncogene] |
|
|
|
| The authors tested senescence markers in human hepatocytes subjected to chronic hyperinsulinemia in vitro and validated the data in vivo by using liver-specific insulin receptor knockout mice. [Molecular Metabolism] |
|
|
|
| Elevated Rho guanine nucleotide exchange factor 2 (ARHGEF2) accelerated HCC angiogenesis via the EDN1 pathway, enhanced HCC cell proliferation and tumor growth both in vitro and in vivo, and contributed to endoplasmic reticulum (ER) stress-related treatment resistance. [Cell Death & Disease] |
|
|
|
| Using a combination of in vitro and in vivo tools, investigators examined the role of hexokinase domain containing 1 (HKDC1) in liver cancer development and progression. [Cell Death & Disease] |
|
|
|
| Scientists demonstrated that human umbilical cord mesenchymal stem cells treatment inhibited hepatic stellate cells activation, protected hepatocytes, and alleviate bile duct ligation-induced liver fibrosis in mice by up-regulating the expression of miR-148-5p and inhibiting the Notch signaling pathway. [Stem Cell Research & Therapy] |
|
|
|
| Investigators showed that overexpression of SIRT7 promoted HCC cell migration and EMT while knockdown of SIRT7 showed opposite effects. Mechanistically, they found that SIRT7 suppressed E-Cadherin expression through FOXO3-dependent promoter binding and H3K18 deacetylation. [Cancer Gene Therapy] |
|
|
|
| Based on 3D organoid culture of HCC-derived cell lines and AAV8-based protein overexpression in the mouse liver, the authors showed that activity modulation of isoform δ of phosphoinositide 3-kinase (PI3Kδ) controlled differentiation and discriminated between stemness and epithelial to mesenchymal transition (EMT). [Communications Biology] |
|
|
|
| Due to the core role of liver cancer stem cells (LCSCs) in HCC metastasis and recurrence, researchers explored the RhoA-YAP1-autophagy pathway in LCSCs under fluid shear stress. [Cell Adhesion & Migration] |
|
|
|
|
| The authors provide insight into technologies available to investigate the tumor microenvironment, and how such technologies are beneficial for improving our understanding of HCC carcinogenesis. [Therapeutic Advances in Medical Oncology] |
|
|
|
| Scientists summarize the published clinical trials of stem cells for the treatment of liver fibrosis/cirrhosis and provide the latest overview of various cell sources, cell doses, and delivery methods. [Stem Cell Research & Therapy] |
|
|
|
|
| MediciNova, Inc. announced the initiation of a Phase II clinical trial to evaluate MN-001 for the treatment of patients with non-alcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus, and hypertriglyceridemia. [MediciNova, Inc. (Globe Newswire, Inc.)] |
|
|
|
|
| October 24 – 26, 2022 Madrid, Spain |
|
|
|
|
|
| Gilead Sciences, Inc. – Foster City, California, United States |
|
|
|
| Mayo Clinic – Scottsdale, Arizona, United States |
|
|
|
| Virginia Commonwealth University – Richmond, Virginia, United States |
|
|
|
| Foundation for Liver Research – London, England, United Kingdom |
|
|
|
| University of North Carolina at Greensboro – Kannapolis, North Carolina, United States |
|
|
|
|